A PILOT STUDY TO EVALUATE AN INTRARENAL INJECTION FOR THE MANAGEMENT OF CHRONIC KIDNEY DISEASE
Principle Investigator
Description
Pilot study to evaluate the field safety and effectiveness of an ultrasound-guided bilateral intrarenal injection of a chemokine for the management of IRIS stages 2 and 3 chronic kidney disease in felines.
Testing Requirements
Owner must be willing to bring their cat to the Veterinary Hospital for 8 study visits over the course of 10 months. They must complete a weekly questionnaire at home (38 weeks) and cats must eat a renal prescription diet throughout the study. This is a placebo-controlled study but placebo cats will have the option of receiving treatment if they have disease progression. Treatment consists of a one-time ultrasound guided injection into each kidney.
Enrollment Start
02/01/2022
Enrollment Finish
02/01/2024
Eligibility
≥ 7 years old, indoor only, diagnosed with IRIS Stages 2 and 3 CKD, good general health (other than CKD)
Flyer
Contact
Katelyn Bennett: 919-515-8380 OR cvmclinicalstudies@ncsu.edu
- Categories: